Agents for PD and Dementia Flashcards
[Side Effects] Levodopa
[Dopaminergic effects]
1. N/V
2. Orthostatic hypotension
3. Hallucinations
4. Drowsiness, sudden sleep onset
L-Dopa induced dyskinesia
Administration cautions for L-DOPA sustained release forms
Do NOT crush. (Sinemet SR)
Do NOT open capsule. (Madopar HBS)
Mgmt of Levodopa - Wearing off
More frequent administration, Sustained release formulation
Mgmt of Levodopa-induced Dyskinesia
Agents:
1. MAO-B inhibitors (Selegiline, Rasagiline)
2. Dopamine agonists (Ropinirole, Pramipexole, Rotigotine (TOP), Apomorphine (SQ))
3. COMT inhibitors (Entacapone)
Sustained-release formulation?
[Side Effects] Anticholinergics
Dry mouth
Constipation
Nausea
Dilated pupils
Urinary retention
Dry Skin
[Side Effects] MAO-Bi (Selegiline)
Dry mouth
Constipation
Nausea
Dilated pupils
Urinary retention
Dry Skin
(!) Orthostatic hypotension
(!) Difficulty sleeping (due to amphetamine metabolite
Which of the following interacts with L-DOPA?
1) Iron
2) Calcium
3) Protein
4) Domperidone
Iron and Protein interferes w L-DOPA absorption. Iron should be taken 2 hrs apart.
Domperidone (D2 antagonist) is useful for emesis. Should NOT use Metoclopramide or Prochlorperazine.
Risperidone should also not be used.
Calcium does not interact w L-DOPA, but does with COMTi.
Sx of L-DOPA-induced dyskinesia
- Involuntary, uncontrollable
- Twitching, jerking
- Peak dose dyskinesia (uncontrolled shakes, tics, tremors)
- Dystonia (involuntary muscle contraction)
Agents for tremor control
- Anticholinergics (Benzhexol, Benztropine)
- NMDA receptor antagonist (Amantadine)
[MoA] Amantadine
- NMDA receptor antagonist
- Dopamine receptor agonist
- Enhanced release of stored dopamine
[Side Effects] NMDA receptor antagonist
- Cognitive impairment
- Hallucination
- Insomnia
- Nightmares
- (!) Livedo Reticularis
[Side Effects] Ropinirole (Dopamine agonist)
- N/V
- Orthostatic hypotension
- Hallucinations
- Somnolence, day-time sleepiness
- (!) Compulsive behaviours
- (!) Leg oedema
Ergots: Fibrosis, Valvular Heart Disease
Place in mgmt of PD - Dopamine agonists
Monotx in young-onset PD;
Adjunct to L-DOPA;
Mgmt of motor complications caused by L-DOPA
Place in mgmt - L-DOPA
Moderate-to-severe Parkinson’s